India Appeals Body Rejects Bayer's Plea to Suspend Sales of Generic Nexavar Fox Business Citing the high cost of the kidney- and liver-cancer medicine, India's patent authority in March forced Bayer to grant a compulsory license on the Nexavar to Natco Pharma so that a cheaper copy of the potentially lifesaving drug will be accessible to ... Bayer's plea for stay on Nexavar generic in India dismissed Patent rights, a fillip for Natco Pharma Bayer plea against Natco on cancer drug dismissed |
